調査・レポート

South Korea's public health initiative 'AGIJIGI' begins recruiting newborns for whole-genome sequencing to identify treatable rare genetic disorders before symptoms appear.

Research published in Science shows cancer cells secrete antioxidant PRDX1 to deplete ROS needed for T‑cell activation, proposing PRDX1 as a new therapeutic target.

A US Solck Institute study in pregnant mice shows that intense immune activation can alter how fetal genes operate, potentially impacting brain development.

A Japanese longitudinal study of 7,644 women shows thyroid function shifts slowly with age rather than sharply at menopause.

A UK Biobank study of over 100,000 adults shows that increasing walking speed reduces death risk, even for low‑step individuals.

Health data shows Korea will have about 998,540 atopic dermatitis patients in 2025, with children under 9 making up roughly 23% of cases, highlighting the need for careful care.

Ewha Womans University Medical Center and Germany's Jena University School of Medicine signed an MOU to launch joint research and education in gender medicine and gender innovation.

Researchers propose using nano-sized particles to deliver immunotherapy agents directly to tumors and release drugs on demand, addressing low response rates and systemic toxicity.

Healthport’s Goodpharm .ai chart now includes a Drug‑Mugger alert, warning pharmacists of nutrient deficiencies linked to long‑term drug use such as statins, metformin and PPIs.

A Seoul Asan Hospital study shows patients with over 20 years of hearing loss from chronic otitis media achieve comparable auditory outcomes to sensorineural patients after cochlear implant surgery.

Beeline Medicines reported its oral lupus drug afimetoran achieved the primary endpoint in a Phase 2 trial and plans pivotal studies for two lupus forms.

Yale analysis of 51 studies reports that healthy diet, regular exercise and certain drugs improve epigenetic aging markers, though researchers warn conclusions are early.